Ischemic optic neuropathy

International Ophthalmology Clinics

Volumn 49, Issue 3, 2009, Pages 35-62

  Delmonte, Derek W ^a   Bhatti, M Tariq ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BRIMONIDINE; C REACTIVE PROTEIN; CORTICOSTEROID; DECONGESTIVE AGENT; FIBRINOGEN; HOMOCYSTEINE; LEVODOPA; METHOTREXATE; METHYLPREDNISOLONE; PHOSPHODIESTERASE V INHIBITOR; PREDNISONE; SILDENAFIL; SUMATRIPTAN;

ANATOMY; ANEMIA; ANTERIOR ISCHEMIC OPTIC NEUROPATHY; ATHEROSCLEROSIS; BLEEDING; BLINDNESS; CAROTID ARTERY DISEASE; CATARACT EXTRACTION; CEREBROVASCULAR DISEASE; CHOROID VASCULARIZATION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; ERECTILE DYSFUNCTION; ERYTHROCYTE SEDIMENTATION RATE; EYE SURGERY; HERPES ZOSTER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; ISCHEMIC OPTIC NEUROPATHY; MIGRAINE; NEUROPROTECTION; NEUROSURGERY; NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY; OPHTHALMIC ARTERY; OPTIC NERVE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; POSTERIOR ISCHEMIC OPTIC NEUROPATHY; PRIORITY JOURNAL; RADIATION INJURY; RENAL REPLACEMENT THERAPY; RETINA BLOOD FLOW; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SHOCK; SICKLE CELL TRAIT; SMOKING; TEMPORAL ARTERITIS; THROMBOCYTE COUNT; TRANSITIONAL BLINDNESS; TRANSVITREAL OPTIC NEUROTOMY; VASOSPASM; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADRENAL CORTEX HORMONES; DIAGNOSIS, DIFFERENTIAL; GIANT CELL ARTERITIS; HUMANS; INCIDENCE; OPTIC NEUROPATHY, ISCHEMIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VISION DISORDERS;

EID: 68949098269     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181a8df6c     Document Type: Review

References (147)

1. Onda E, Cioffi GA, Bacon DR, et al. Microvasculature of the human optic nerve. Am J Ophthalmol. 1995;120:92-102.
2. Hayreh SS. The blood supply of the optic nerve head and the evaluation of it-myth and reality. Prog Retin Eye Res. 2001;20:563-593.
3. Mackenzie PJ, Cioffi GA. Vascular anatomy of the optic nerve head. CanJ Ophthalmol. 2008;43:308-312.
4. Liu NH, LaBree LD, Feldon SE, et al. The epidemiology of giant cell arteritis: a 12-year retrospective study. Ophthalmology. 2001;108:1145-1149.
5. Johnson LN, Arnold AC. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol. 1994; 14:38-44.
6. Rahman W, Rahman FZ. Giant cell (temporal) arteritis: an overview and update. Surv Ophthalmol. 2005;50:415-428.
7. Henkind P, Charles NC, Pearson J. Histopathology of ischemic optic neuropathy. AmJ Ophthalmol. 1970;69:78-90.
8. Rootman J, Butler D. Ischaemic optic neuropathy-a combined mechanism. Br J Ophthalmol. 1980;64:826-831.
9. Nordborg E, Nordborg C. Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology (Oxford). 2003;42: 413-421.
10. Liu GT, Glaser JS, Schatz NJ, et al. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology. 1994;101:1779-1785.
11. Aiello PD, Trautmann JC, McPhee TJ, et al. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550-555.
12. Hayreh SS, Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica. 2003;217:239-259.
13. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. AmJ Ophthalmol. 1998; 125:509-520. (Pubitemid 28236919)
14. Hayreh SS, Podhajsky PA, Raman R, et al. Giant cell arteritis: validity and reliability of various diagnostic criteria. AmJ Ophthalmol. 1997; 123:285-296.
15. Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis. 1981;40:1-5.
16. Quigley H, Anderson DR. Cupping of the optic disc in ischemic optic neuropathy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83:755-762.
17. Sebag J, Thomas JV, Epstein DL, et al. Optic disc cupping in arteritic anterior ischemic optic neuropathy resembles glaucomatous cupping. Ophthalmology. 1986;93:357-361.
18. Danesh-Meyer HV, Savino PJ, Sergott RC. The prevalence of cupping in end-stage arteritic and nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2001; 108:593-598.
19. Hayreh SS, Jonas JB. Optic disc morphology after arteritic anterior ischemic optic neuropathy. Ophthalmology. 2001;108:1586-1594.
20. Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed). 1983;286:266.
21. Zweegman S, Makkink B, Stehouwer CD. Giant-cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature. Neth J Med. 1993;42:128-131.
22. Small JM, Ga Vrilescu K. The serum protein changes in giant cell arteritis. J Neurol Neurosurg Psychiatry. 1963;26:257-261.
23. Eshaghian J, Goeken JA. C-reactive protein in giant cell (cranial, temporal) arteritis. Ophthalmology. 1980;87:1160-1166.
24. Parikh M, Miller NR, Lee AG, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006;113:1842-1845.
25. Krishna R, Kosmorsky GS. Implications of thrombocytosis in giant cell arteritis. Am J Ophthalmol. 1997;124:103.
26. Liozon E, Herrmann F, Ly K, et al. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. AmJMed. 2001;1 11:211-217.
27. Albert DM, Ruchman MC, Keltner JL. Skip areas in temporal arteritis. Arch Ophthalmol. 1976;94:2072-2077.
28. Boyev LR, Miller NR, Green WR. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol. 1999; 128:211-215.
29. Danesh-Meyer HV, Savino PJ, Eagle RC Jr, et al. Low diagnostic yield with second biopsies in suspected giant cell arteritis.JNeuroophthalmol. 2000;20:213-215.
30. Pless M, Rizzo JF III, Lamkin JC, et al. Concordance of bilateral temporal artery biopsy in giant cell arteritis.J Neuroophthalmol. 2000;20:216-218.
31. Borruat FX, Herbort CP. Herpes zoster ophthalmicus. Anterior ischemic optic neuropathy and acyclovir.J Clin Neuroophthalmol. 1992;12:37-40.
32. Crompton JL, Iyer P, Begg MW. Vasculitis and ischaemic optic neuropathy associated with rheumatoid arthritis. AustJ Ophthalmol. 1980;8:219-239.
33. Hsu CT, Kerrison JB, Miller NR, et al. Choroidal infarction, anterior ischemic optic neuropathy, and central retinal artery occlusion from polyarteritis nodosa. Retina. 2001;21:348-351.
34. Isaak BL, Liesegang TJ, Michet CJ Jr. Ocular and systemic findings in relapsing polychondritis. Ophthalmology. 1986;93:681-689.
35. Beri M, Klugman MR, Kohler JA, et al. Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology. 1987;94: 1020-1028.
36. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology. 2003;110:1204-1215.
37. Guevara RA, Newman NJ, Grossniklaus HE. Positive temporal artery biopsy 6 months after prednisone treatment. Arch Ophthalmol. 1998;116:1252-1253.
38. Hayreh SS, Zimmerman B, Kardon RH. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol Scand. 2002;80:355-367.
39. Chan CC, Paine M, O'Day J. Steroid management in giant cell arteritis. Br J Ophthalmol. 2001;85:1061-1064.
40. Cornblath WT, Eggenberger ER. Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone. Ophthalmology. 1997;104: 854-858.
41. Spiera RF, Mitnick HJ, Kupersmith M, et al. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol. 2001;19:495-501.
42. Jover JA, Hernandez-Garcia C, Morado IC, et al. Combined treatment of giant-cell arteritis with methotrexate and prednisone a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001;134:106-114.
43. Hoffman GS, Cid MC, Hellmann DB, et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002;46:1309-1318.
44. Nesher G, Berkun Y, Mates M, et al. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum. 2004;50:1332-1337. (Pubitemid 38480844)
45. Weyand CM, Kaiser M, Yang H, et al. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum. 2002;46:457-466.
46. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. / Neuroophthalmol. 2003;23:157-163.
47. Miller NR, Walsh FB, Hoyt WF. Walsh and Hoyt's Clinical neuro-ophthalmology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2005:2290-2294.
48. Ischemic Optic Neuropathy Decompression Trial Study Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996; 114: 1366-1374.
49. Hattenhauer MG, Leavitt JA, Hodge DO, et al. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997;123:103-107.
50. Repka MX, Savino PJ, Schatz NJ, et al. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol. 1983;96:478-483.
51. Boghen DR, Glaser JS. Ischaemic optic neuropathy. The clinical profile and history. Brain. 1975;98:689-708.
52. Hayreh SS, Joos KM, Podhajsky PA, et al. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. AmJ Ophthalmol. 1994; 118:766-780.
53. Hayreh SS, Jonas JB, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy and tobacco smoking. Ophthalmology. 2007;1 14:804-809.
54. Peric S, Cerovski B, Peric P. Anterior ischaemic optic neuropathy in patient with rheumatoid arthritis-case report. Coll Antropol. 2001;25(suppl):67-70.
55. Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115(2 suppl):S3-S12.
56. Preechawat P, Bruce BB, Newman NJ, et al. Anterior ischemic optic neuropathy in patients younger than 50 years. AmJ Ophthalmol. 2007;144:953-960.
57. Slavin ML, Barondes MJ. Ischemic optic neuropathy in sickle cell disease. Am J Ophthalmol. 1988;105:212-213.
58. Lee AG, Brazis PW, Miller NR. Posterior ischemic optic neuropathy associated with migraine. Headache. 1996;36:506-510.
59. Mathews MK. Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol. 2005;16:341-345.
60. Weger M, Stanger O, Deutschmann H, et al. Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy. Br J Ophthalmol. 2001;85:803-806.
61. Kawasaki A, Purvin VA, Burgett RA. Hyperhomocysteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol. 1999;83: 1287-1290.
62. Biousse V, Kerrison JB, Newman NJ. Is non-arteritic anterior ischaemic optic neuropathy related to homocysteine? Br J Ophthalmol. 2000;84:555.
63. Salomon O, Huna-Baron R, Kurtz S, et al. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 1999;106:739-742.
64. Cordeiro MF, Lloyd ME, Spalton DJ, et al. Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an anti-phospholipid positive patient with systemic lupus erythematosus. J Neurol Neurosurg Psychiatry. 1994;57:1142-1143.
65. Bessero AC, Borruat FX. Visual dysfunction and arterial occlusion: is there an association with factor V Leiden mutation? Four case reports.J Fr Ophtalmol. 2006; 29:43-46.
66. Mojon DS, Hedges TR III, Ehrenberg B, et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2002;120:601-605. (Pubitemid 34496611)
67. Knox DL, Kerrison JB, Green WR. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc. 2000;98:203-220; discussion 21-22.
68. Hayreh SS, Zimmerman MB, Podhajsky P, et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;1 17:603-624.
69. Burde RM. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. AmJ Ophthalmol. 1993;116:759-764.
70. Beck RW, Servais GE, Hayreh SS. Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology. 1987;94:1503-1508.
71. Beck RW, Savino PJ, Repka MX, et al. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology. 1984;91:1334-1337.
72. Chen CS, Johnson MA, Flower RA, et al. A primate model of nonarteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2008;49:2985-2992.
73. Swartz NG, Beck RW, Savino PJ, et al. Pain in anterior ischemic optic neuropathy. J Neuroophthalmol. 1995;15:9-10.
74. Rizzo JF III, Lessell S. Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol. 1991;109:1668-1672.
75. Cheng MA, Sigurdson W, Tempelhoff R, et al. Visual loss after spine surgery: a survey. Neurosurgery. 2000;46:625-630; discussion 30-31.
76. Olver JM, Spalton DJ, McCartney AC. Microvascular study of the retrolaminar optic nerve in man: the possible significance in anterior ischaemic optic neuropathy. Eye. 1990;4(Pt 1):7-24.
77. Mansour AM, Shoch D, Logani S. Optic disk size in ischemic optic neuropathy. AmJ Ophthalmol. 1988;106:587-589.
78. Borchert M, Lessell S. Progressive and recurrent nonarteritic anterior ischemic optic neuropathy. AmJ Ophthalmol. 1988; 106:443-449.
79. Hayreh SS, Podhajsky PA, Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. AmJ Ophthalmol. 2001;132:734-742.
80. The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995;273:625-632.
81. Hayreh SS, Zimmerman B. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination. Arch Ophthalmol. 2005;123:1554-1562.
82. Bellusci C, Savini G, Carbonelli M, et al. Retinal nerve fiber layer thickness in nonarteritic anterior ischemic optic neuropathy: OCT characterization of the acute and resolving phases. Graefes Arch Clin Exp Ophthalmol. 2008;246:641-647.
83. Hedges TR III, Vuong LN, Gonzalez-Garcia AO, et al. Subretinal fluid from anterior ischemic optic neuropathy demonstrated by optical coherence tomography. Arch Ophthalmol. 2008;126:812-815.
84. Arnold AC, Hepler RS. Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994;117:222-230.
85. Friedland S, Winterkorn JM, Burde RM. Luxury perfusion following anterior ischemic optic neuropathy. J Neuroophthalmol. 1996;16:163-171.
86. Keltner JL, Becker B, Gay AJ, et al. Effect of diphenylhydantoin in ischemic optic neuritis. Trans Am Ophthalmol Soc. 1972;70:1 13-130.
87. Kollarits CR, McCarthy RW, Corrie WS, et al. Norepinephrine therapy of ischemic optic neuropathy.J Clin Neuroophthalmol. 1981;1:283-288.
88. Smith JL. Norepinephrine therapy of ischemic optic neuropathy.J Clin Neuroophthalmol. 1981;1:289-290.
89. Johnson LN, Guy ME, Krohel GB, et al. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000; 107:521-526.
90. Hayreh SS. Does Levodopa improve visual function in NAION? Ophthalmology. 2000;107:1434-1438.
91. Kupersmith MJ, Frohman L, Sanderson M, et al. Aspirin reduces the incidence of second eye NAION: a retrospective study.J Neuroophthalmol. 1997;17:250-253.
92. Salomon O, Huna-Baron R, Steinberg DM, et al. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye. 1999;13(Pt 3a):357-359.
93. Beck RW, Hayreh SS, Podhajsky PA, et al. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997; 123:212-217.
94. Sergott RC, Cohen MS, Bosley TM, et al. Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol. 1989;107:1743-1754.
95. Spoor TC, Wilkinson MJ, Ramocki JM. Optic nerve sheath decompression for the treatment of progressive nonarteritic ischemic optic neuropathy. Am J Ophthalmol. 1991;111:724-728.
96. Soheilian M, Koochek A, Yazdani S, et al. Transvitreal optic neurotomy for nonarteritic anterior ischemic optic neuropathy. Retina. 2003;23:692-697.
97. Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol. 2008;246:1029-1046.
98. Lieberman TW. Ocular effects of prolonged systemic drug administration. (Corti-costeroids, chloramphenicol and anovulatory agents). Dis Nerv Syst. 1968;29(suppl): 44-50.
99. Jonas JB, Spandau UH, Harder B, et al. Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2007;245:749-750.
100. Kaderli B, Avci R, Yucel A, et al. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2007;27:164-168.
101. Danylkova NO, Alcala SR, Pomeranz HD, et al. Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy. Exp Eye Res. 2007;84:293-301.
102. Fazzone HE, Kupersmith MJ, Leibmann J. Does topical brimonidine tartrate help NAION? Br J Ophthalmol. 2003;87:1193-1194.
103. Wilhelm B, Ludtke H, Wilhelm H. Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol. 2006;244:551-558.
104. Carter JE. Chronic ocular ischemia and carotid vascular disease. Stroke. 1985; 16:721-728.
105. Muller M, Kessler C, Wessel K, et al. Low-tension glaucoma: a comparative study with retinal ischemic syndromes and anterior ischemic optic neuropathy. Ophthalmic Surg. 1993;24:835-838.
106. Fry CL, Carter JE, Kanter MC, et al. Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis. Stroke. 1993;24:539-542.
107. Newman NJ. Perioperative visual loss after nonocular surgeries. Am J Ophthalmol. 2008;145:604-610.
108. Chang SH, Miller NR. The incidence of vision loss due to perioperative ischemic optic neuropathy associated with spine surgery: the Johns Hopkins Hospital Experience. Spine. 2005;30:1299-1302.
109. McCulley TJ, Lam BL, Feuer WJ. Nonarteritic anterior ischemic optic neuropathy and surgery of the anterior segment: temporal relationship analysis. AmJ Ophthalmol. 2003;136:1171-1172.
110. Hayreh SS. Anterior ischemic optic neuropathy. IV. Occurrence after cataract extraction. Arch Ophthalmol. 1980;98:1410-1416.
111. Kim R, Van Stavern G, Juzych M. Nonarteritic anterior ischemic optic neuropathy associated with acute glaucoma secondary to Posner-Schlossman syndrome. Arch Ophthalmol. 2003;121:127-128.
112. Lam BL, Jabaly-Habib H, Al-Sheikh N, et al. Risk of non-arteritic anterior ischaemic optic neuropathy (NAION) after cataract extraction in the fellow eye of patients with prior unilateral NAION. BrJ Ophthalmol. 2007;91:585-587.
113. McCulley TJ, Lam BL, Feuer WJ. A comparison of risk factors for postoperative and spontaneous nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2005;25:22-24.
114. Troger J, Kieselbach G, Gottinger W, et al. Different concentrations of vasoactive intestinal polypeptide in aqueous humor of patients with proliferative vitreoretino-pathy and cataract patients. Ger J Ophthalmol. 1994;3:245-247.
115. Elston J. Non-arteritic anterior ischaemic optic neuropathy and cataract surgery. BrJ Ophthalmol. 2007;91:563.
116. McCulley TJ, Lam BL, Feuer WJ. Incidence of nonarteritic anterior ischemic optic neuropathy associated with cataract extraction. Ophthalmology. 2001;108:1275-1278.
117. Hollenhorst RW, Wegener HP. Loss of vision after distant hemorrhage. AmJMed Sci. 1950;219:209-218.
118. Chisholm IA. Optic neuropathy of recurrent blood loss. Br J Ophthalmol. 1969; 53:289-295.
119. Katz DM, Trobe JD, Cornblath WT, et al. Ischemic optic neuropathy after lumbar spine surgery. Arch Ophthalmol. 1994;112:925-931.
120. Hayreh SS. Anterior ischemic optic neuropathy. VIII. Clinical features and pathogenesis of post-hemorrhagic amaurosis. Ophthalmology. 1987;94:1488-1502.
121. Foroozan R, Buono LM, Savino PJ. Optic disc structure and shock-induced anterior ischemic optic neuropathy. Ophthalmology. 2003;110:327-331.
122. Choi JH, Choi KD, Kim JS, et al. Simultaneous posterior ischemic optic neuropathy, cerebral border zone infarction, and spinal cord infarction after correction of malignant hypertension. J Neuroophthalmol. 2008;28:198-201.
123. Kline LB, Kim JY, Ceballos R. Radiation optic neuropathy. Ophthalmology. 1985; 92:1118-1126.
124. Roden D, Bosley TM, Fowble B, et al. Delayed radiation injury to the retrobulbar optic nerves and chiasm. Clinical syndrome and treatment with hyperbaric oxygen and corticosteroids. Ophthalmology. 1990;97:346-351.
125. Jiang GL, Tucker SL, Guttenberger R, et al. Radiation-induced injury to the visual pathway. Radiother Oncol. 1994;30:17-25.
126. Guy J, Schatz NJ. Hyperbaric oxygen in the treatment of radiation-induced optic neuropathy. Ophthalmology. 1986;93:1083-1088.
127. Harris JR, Levene MB. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology. 1976; 120:167-171.
128. Lessell S. Friendly fire: neurogenic visual loss from radiation therapy. J Neuroophthalmol. 2004;24:243-250.
129. Lessell S. Magnetic resonance imaging signs may antedate visual loss in chiasmal radiation injury. Arch Ophthalmol. 2003;121:287-288.
130. Danesh-Meyer HV Radiation-induced optic neuropathy.J Clin Neurosci. 2008; 15: 95-100.
131. Servilla KS, Groggel GC. Anterior ischemic optic neuropathy as a complication of hemodialysis. AmJ Kidney Dis. 1986;8:61-63.
132. Hamed LM, Winward KE, Glaser JS, et al. Optic neuropathy in uremia. Am J Ophthalmol. 1989;108:30-35.
133. Korzets A, Marashek I, Schwartz A, et al. Ischemic optic neuropathy in dialyzed patients: a previously unrecognized manifestation of calcific uremic arteriolopathy. Am J Kidney Dis. 2004;44:e93-e97.
134. Chiari M, Manzoni GC, Van de Geijn EJ. Ischemic optic neuropathy after sumatriptan in a migraine with aura patient. Headache. 1994;34:237-238.
135. Bella AJ, Brant WO, Lue TF, et al. Non-arteritic anterior ischemic optic neuropathy (NAION) and phosphodiesterase type-5 inhibitors. CanJ Urol. 2006; 13:3233-3238.
136. Younge BR. Amiodarone and ischemic optic neuropathy. J Neuroophthalmol. 2007; 27:85-86.
137. Fivgas GD, Newman NJ. Anterior ischemic optic neuropathy following the use of a nasal decongestant. AmJ Ophthalmol. 1999; 127:104-106.
138. Margo CE, French DD. Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors. AmJ Ophthalmol. 2007;143:538-539.
139. French DD, Margo CE. Post-marketing surveillance of ischaemic optic neuropathy in male veterans co-prescribed phosphodiesterase-5 inhibitors with organic nitrates or alpha-blockers. Drug Saf. 2008;31:241-247.
140. Danesh-Meyer HV, Levin LA. Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association? Br J Ophthalmol. 2007; 91:1551-1555.
141. Sadda SR, Nee M, Miller NR, et al. Clinical spectrum of posterior ischemic optic neuropathy. AmJ Ophthalmol. 2001;132:743-750.
142. Hayreh SS. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye. 2004; 18:1188-1206.
143. Hayreh SS. Posterior ischemic optic neuropathy. Ophthalmologica. 1981;182:29-41.
144. Fontal MR, Kerrison JB, Garcia R, et al. Ischemic optic neuropathy. Semin Neurol. 2007;27:221-232.
145. Alexandrakis G, Lam BL. Bilateral posterior ischemic optic neuropathy after spinal surgery. Am J Ophthalmol. 1999;127:354-355.
146. Marks SC, Jaques DA, Hirata RM, et al. Blindness following bilateral radical neck dissection. Head Neck. 1990;12:342-345.
147. Rizzo JF III, Lessell S. Posterior ischemic optic neuropathy during general surgery. AmJ Ophthalmol. 1987;103:808-811.